BE745022A - Composition pharmaceutique - Google Patents

Composition pharmaceutique

Info

Publication number
BE745022A
BE745022A BE745022DA BE745022A BE 745022 A BE745022 A BE 745022A BE 745022D A BE745022D A BE 745022DA BE 745022 A BE745022 A BE 745022A
Authority
BE
Belgium
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
Other languages
English (en)
Inventor
D C Delong
W J Doran
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BE745022A publication Critical patent/BE745022A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/62—Barbituric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE745022D 1969-01-29 1970-01-28 Composition pharmaceutique BE745022A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79507969A 1969-01-29 1969-01-29

Publications (1)

Publication Number Publication Date
BE745022A true BE745022A (fr) 1970-07-28

Family

ID=25164610

Family Applications (1)

Application Number Title Priority Date Filing Date
BE745022D BE745022A (fr) 1969-01-29 1970-01-28 Composition pharmaceutique

Country Status (3)

Country Link
AU (1) AU1048070A (fr)
BE (1) BE745022A (fr)
DE (1) DE2003994A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674870A (en) * 1995-02-13 1997-10-07 Gulliya; Kirpal S. Anti-cancer uses for barbituric acid analogs
US5869494A (en) * 1995-02-13 1999-02-09 Gulliya; Kirpal S. Uses for barbituric acid analogs

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050096319A1 (en) * 2003-02-21 2005-05-05 Balzarini Jan M.R. Identification of compounds that inhibit replication of human immunodeficiency virus

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674870A (en) * 1995-02-13 1997-10-07 Gulliya; Kirpal S. Anti-cancer uses for barbituric acid analogs
US5869494A (en) * 1995-02-13 1999-02-09 Gulliya; Kirpal S. Uses for barbituric acid analogs

Also Published As

Publication number Publication date
AU1048070A (en) 1971-07-22
DE2003994A1 (de) 1970-07-30

Similar Documents

Publication Publication Date Title
BE752620A (fr) Composition antiseptique
BR6915181D0 (pt) Compostos amino-benzo-ciclo-alcanos
BE768269A (fr) Composition pharmaceutique
AT308283B (de) Riechstoffkomposition
BR6915289D0 (pt) Composicao inativante contendo etiletilenimina
BE749864A (fr) Nouvelle composition pharmaceutique effervescente
CH496439A (de) Mischkapsel
SE386456B (sv) Ytaktiv komposition
BE775640A (fr) Composition pharmaceutique
AT300379B (de) Weichmacherzusammensetzung
AT305642B (de) Polymer-Zusammensetzung
DE2003713B2 (de) Zirkulator
BE776769A (fr) Composition pharmaceutique
BR6915243D0 (pt) Compostos sulfonamidicos
BE770399A (fr) Composition pharmaceutique
CH527559A (fr) Composition pesticide
BE760328A (fr) Nouvelle association medicamenteuse
AT293293B (de) Deodorisierungsgerät
AT309896B (de) Pestizide Zusammensetzung
BE745022A (fr) Composition pharmaceutique
BR7018170D0 (pt) Composicao polimera
CH522030A (de) Riechstoffkomposition
BR6915336D0 (pt) Reptidios contendo tirosina-o-sulfato
BE752809R (fr) Preparation
BE756973A (fr) Hydroxyphenyl-2-piperidinylcarbinols et compositions pharmaceutiques encontenant